title: Cholestyramine treats primary sclerosing cholangitis-associated inflammatory bowel disease.
authors.affiliation: Gastroenterology Department, King's College Hospital, London, UK.
authors.forename: Polychronis
authors.initials: P
authors.lastname: Pavlidis
authors.affiliation: Institute of Liver Studies, King's College Hospital, London, UK.
authors.forename: Michael
authors.initials: M
authors.lastname: Heneghan
authors.affiliation: Gastroenterology Department, King's College Hospital, London, UK.
authors.forename: Bu'Hussain
authors.initials: B
authors.lastname: Hayee
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use; D015209:Cholangitis, Sclerosing / Q000150:complications / Q000188:drug therapy*; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000150:complications*; D003424:Crohn Disease / Q000150:complications*; D006801:Humans
chemical_list: D000924:Anticholesteremic Agents; D002792:Cholestyramine Resin